Cardiac Resynchronization Therapy Defibrillator Based Impedance Monitoring Study

Completed · Not applicable

Conditions studied: Heart Failure

In brief

The intent of this feasibility study is to collect and analyze intra-thoracic impedance measurements from a CRT-D device in a heart failure population.

Key facts

Study ID

NCT00500838

Run by

Abbott Medical Devices

People needed

75

Starts

2007-07-01

Expected to finish

2008-08-01

Last updated by the study team

2019-02-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Eligible patients will meet all of the following:
• Have an approved indication per American College of Cardiology/American Heart Association/Heart Rhythm Society guidelines for implantation of a Cardiac Resynchronization Therapy Defibrillator (CRT-D) or have a previously implanted St. Jude Medical (SJM) CRT-D system capable of enabling the diagnostic impedance monitoring feature with implant occurring within the last 14 days
• Have had at least one hospitalization, emergency department visit, or clinic visit within the past 12 months for treatment of decompensated heart failure requiring intravenous diuretics, intravenous inotropes, Natrecor (Nesiritide) therapy, or an increase in an oral diuretic of ≥100% over a 24 hour period
• Have the ability to maintain a patient diary for recording daily weights, symptoms related to heart failure, changes in diuretic therapy, and any unscheduled clinic or hospital visits
• Have the ability to provide informed consent for study participation and be willing and able to comply with the prescribed follow-up tests and schedule of evaluation

You may not qualify if…

• Patients will be excluded if they meet any of the following:
• Be less than 18 years of age
• Have had a recent myocardial infarction, unstable angina or cardiac revascularization within 40 days of enrollment
• Have had a recent Cerebrovascular Accident or Transient Ischemic Attack within three months of enrollment
• Have a contraindication for an emergency thoracotomy
• Have an indication that requires programming device in atrial pacing mode
• Have permanent (chronic) atrial fibrillation
• Have a capped or inactive right atrial or right ventricular pacing/defibrillator lead
• Have a hypersensitivity to a single 1.0mg dose of dexamethasone sodium phosphate or short term contact with heparin
• Be pregnant or planning a pregnancy in the next 6-months
• Be currently participating in a clinical investigation that includes an active treatment arm
• Have a life expectancy of less than six months due to any condition

Where it is running

• Baptist Health Medical Center — Little Rock, Arkansas, United States
• Glendale Memorial Hospital — Glendale, California, United States
• Deborah Heart and Lung — Browns Mills, New Jersey, United States
• Medical University of South Carolina — Charleston, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.